SM Kim, et al. INTRAOCULAR LENS EXCHANGE Table 1. Summary of cases Case In(tMerov)al InOitpial DgrMadRe comOocrubliadrities 1 57.5 PE PCL - ST BRVO 2 50.1 PE PCL 1 3 53.2 PE PCL - Strabismus 4 53.9 PE PCL - 5 49.6 PE PCL - 6 50.1 PE PCL 1 7 50.8 PE PCL 4 8 49.0 ECCE - 9 57.3 PE PCL 1 10 56.9 PE PCL 3 11 * 51.9 PE PCL - 12 * 56.4 ECCE - 13 67.5 PE PCL 1 14 * 53.3 PE PCL - Glaucoma 15 * 53.4 PE PCL - Glaucoma 16 * 49.8 PE PCL - 17 * 64.7 PE PCL - 18 * 63.5 PE PCL - Glaucoma 19 57.6 PE PCL - 20 * 67.2 PE PCL - 21 * 62.7 PE PCL 1 22 * 54.0 PE PCL - 23 * 53.3 PE PCL - 24 * 66.7 PE PCL - 25 * 58.3 PE PCL 1 26 * 60.8 PE PCL 1 27 * 54.4 PE PCL - 28 * 54.8 PE PCL - Orbital Mass 29 * 63.9 PE PCL - 30 * 59.7 PE PCL - 31 * 55.1 PE PCL - 32 * 55.9 PE PCL - 33 * 65.3 PE PCL - 34 * 61.3 PE PCL - 35 * 61.5 PE PCL - 36 * 62.7 PE PCL 4 37 * 61.6 PE PCL - 38 66.9 PE PCL - 39 * 62.3 PE PCL 3 40 * 62.0 PE PCL - 41 * 58.6 PE PCL - 42 * 73.2 PE PCL - OHT 43 * 63.4 PE PCL - 44 * 61.0 PE PCL - 45 * 64.6 PE PCL - 46 * 70.5 PE PCL 1 47 * 64.9 ECCE - Glaucoma 48 * 75.8 PE PCL 1 49 * 74.8 PE PCL - 50 * 67.3 PE PCL 1 51 * 69.3 PE PCL 4 52 * 81.3 PE PCL - * Cases included in the analysis of refractive prediction † All VA values are in decimal scale. Mo=months DMR grade 1=no diabetic retinopathy DMR grade 3=mild nonproliferative diabetic retinopathy DMR grade 4=moderate nonproliferative diabetic retinopathy OHT=ocular hypertension B=in-the-bag IOL implantation B-S=in-the-sulcus IOL implantation or optic capture IOL Impl. B S S B S S S S S B S B S S S B S S B S S S S S S S S S S S S S S S S S S S S B S S B B B B B S S B S S F/U (Mo) 10.8 37.8 38.5 19.2 27.8 29.8 36.5 2.1 32.8 28.9 31.3 31.9 2.8 18.2 18.2 6.0 26.7 20.6 29.1 2.5 3.8 2.1 1.5 23.4 24.7 20.0 16.2 12.8 4.7 1.9 12.1 19.6 19.1 10.3 10.3 14.2 26.8 2.0 25.5 10.6 1.6 20.3 3.7 2.7 18.5 12.9 20.9 5.9 3.1 3.2 1.6 2.4 BC1V†A BC2V†A BC3V†A A-V Z-D I-D Prev. PCI 0.1 0.08 0.1 1.0 0.4 1.0 1.0 0.6 0.8 1.0 0.7 0.9 0.8 0.4 0.7 0.9 0.5 1.0 1.0 0.8 1.0 0.8 0.6 0.8 1.0 0.8 1.0 1.0 0.6 1.0 0.8 0.7 0.8 A-V Z-D 0.9 0.5 0.9 A-V + 0.9 0.6 0.9 0.9 0.5 0.8 1.0 0.6 0.8 1.0 0.5 0.9 1.0 0.3 0.9 A-V + 0.9 0.3 0.9 Z-D 1.0 0.4 1.0 Z-D 1.0 0.3 0.9 A-V + 1.0 0.5 1.0 0.9 0.4 0.8 0.5 0.001 0.7 1.0 0.7 1.0 1.0 0.7 1.0 1.0 0.5 1.0 1.0 0.7 1.0 1.0 0.3 1.0 0.7 0.4 0.7 1.0 0.3 1.0 1.0 0.5 0.9 0.9 0.4 1.0 1.0 0.6 1.0 0.8 0.4 0.8 I-D 0.9 0.4 0.8 0.7 0.5 0.8 0.9 0.5 0.8 ? 0.2 0.4 1.0 0.5 1.0 0.8 0.4 0.8 A-V Z-D 0.8 0.6 0.8 0.8 0.5 0.7 A-V + 0.9 0.7 1.0 1.0 0.5 1.0 1.0 0.5 1.0 1.0 0.3 0.8 0.6 0.3 0.6 1.0 0.4 1.0 A-V + 0.9 0.5 1.0 1.0 0.5 1.0 1.0 0.3 1.0 1.0 0.4 1.0 BCVA 1=BCVA after initial IOL implantation BCVA 2=BCVA before IOL exchange BCVA 3=BCVA after IOL exchange A-V=anterior vitrectomy Z-D=zonular dehiscence I-D=iridodialysis Prev. PCI=previous posterior capsule incompetency identified Nd:YAG P-C=post-exchange Nd:YAG posterior capsulotomy Nd:YAG P-C + + + + + + + + 231